LUNG
Pulmonx CorpNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$54.06M
P/E Ratio
—
EPS
$-1.33
Beta
0.19
52W High
$5.49
52W Low
$1.13
50-Day MA
$1.53
200-Day MA
$1.90
Dividend Yield
—
Profit Margin
-59.70%
Forward P/E
28.33
PEG Ratio
—
About Pulmonx Corp
Pulmonx Corporation, a medical technology company, designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. The company is headquartered in Redwood City, California.
Fundamentals
| Revenue (TTM) | $90.50M |
| Gross Profit (TTM) | $67.14M |
| EBITDA | $-52.61M |
| Operating Margin | -43.80% |
| Return on Equity | -77.20% |
| Return on Assets | -23.00% |
| Revenue/Share (TTM) | $2.22 |
| Book Value | $1.30 |
| Price-to-Book | 1.04 |
| Price-to-Sales (TTM) | 0.60 |
| EV/Revenue | 0.473 |
| EV/EBITDA | -5.62 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -4.90% |
| Shares Outstanding | $42.24M |
| Float | $37.39M |
| % Insiders | 10.50% |
| % Institutions | 81.79% |
Analyst Ratings
Consensus ($5.17 target)
4
Buy2
HoldData last updated: 4/8/2026